AdvanSix (ASIX) Q2 Revenue Falls 10%
(NYSE:ASIX), a U.S.-based producer of essential chemicals, released results on August 1, 2025, covering the three months ended June 30. The headline was a mixed performance: adjusted diluted earnings per share (Non-GAAP) came in at $1.24, beating the $1.185 analyst estimate by 4.6%, but revenue (GAAP) of $410 million missed expectations, coming in 4.3% below the $428.4 million GAAP consensus. Compared to Q2 2024, revenue (GAAP) slipped 9.6%, and adjusted EBITDA (non-GAAP) dropped 28.8% versus Q2 2024. The quarter showed resilience in certain areas, especially Plant Nutrients, but exposed ongoing pressures from weaker market demand, notably in Nylon and Chemical Intermediates.
Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report.
AdvanSix is a leading manufacturer of Nylon 6 resin, caprolactam (used as a feedstock for nylon production), plant nutrients like ammonium sulfate fertilizer, and several chemical intermediates including acetone and phenol. Its operations are heavily vertically integrated, with large-scale manufacturing capability concentrated in the United States. The company’s Hopewell facility is one of the world's top sites for producing caprolactam and ammonium sulfate, which helps drive efficiency and cost benefits.
Source Fool.com
AdvanSix Inc Stock
With 0 Sell predictions and 2 Buy predictions the community sentiment towards the AdvanSix Inc stock is not clear.
With a target price of 32 € there is potential for a 128.57% increase which would mean more than doubling the current price of 14.0 € for AdvanSix Inc.
